| % adherence (mean (range)) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Treatment | n | Sofosbuvir (SOF) | Daclatasvir (DCV) | Simeprevir (SMV) | Ribavirin (RBV) | (OPR)* | Dasabuvir (DSV) | Ledipasvir (LDV)-SOF |
| SOF/DCV SOF/DCV/RBV | 12 4 | 99.6 (98- 100) 100 | 99.6 (98–100) 100 | - - | - 100 | - - | - - | - - |
| SMV/SOF SMV/SOF/R BV | 3 23 | 99.7 (99–100) 99.9 (98–100) | - - | 99.7 (99–100) 99.9 (98–100) | - 99.2 (92–100) | - - | - - | - - |
| OPR/DSB OPR/DSB/RBV | 11 9 | - - | - - | - - | - 99.3 (98–100) | 100 99.8 (99–100) | 100 99.7 (98–100) | - - |
| LDP-SOF LDP-SOF/RBV | 2 14 | - - | - - | - - | - 99.2 (96–100) | - - | - - | 100 99.9 (99–100) |
↵* OPR, ombitasvir/paritaprevir/ritonavir.